Income Statement bioMérieux

Equities

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris Other stock markets 16:00:04 08/06/2026 BST			5-day change	1st Jan Change
71.90 ^EUR	-1.30%		+0.49%	-34.86%

06-04	What Bundibugyo Ebola vaccines and treatments are under development	RE
06-01	BioMérieux in the red following UBS downgrade

a9ca5.JPYf7cWuhyeNATK0kOC01j68LyvUm6Ekw4cImWQwfWs.fMdm2YbAwnHXTgbd96ry51fbVh_l8OpjgcxwoBxAJSxIvXiLhurlcehZZw

Published financial data: BIOMÉRIEUX

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	3.38B	3.59B	3.67B	3.98B	4.07B
Total Revenues	3.38B	3.59B	3.67B	3.98B	4.07B
Cost of Goods Sold, Total	1.41B	1.58B	1.62B	1.76B	1.76B
Gross Profit	1.96B	2.01B	2.06B	2.22B	2.31B
Selling General & Admin Expenses, Total	818M	955M	1.02B	1.1B	1.11B
R&D Expenses	389M	447M	460M	492M	507M
Depreciation & Amortization - (IS)	-	-	40.7M	35.2M	33.2M
Amortization of Goodwill and Intangible Assets - (IS)	-	38M	-	-	-
Other Operating Expenses	-44.6M	-43.6M	-33M	-46.9M	-37.8M
Other Operating Expenses, Total	1.16B	1.4B	1.49B	1.58B	1.61B
Operating Income	801M	613M	569M	638M	695M
Interest Expense, Total	-9.1M	-4.1M	-4.4M	-16M	-15.8M
Interest And Investment Income	1.7M	1.2M	1.1M	14.4M	14.3M
Net Interest Expenses	-7.4M	-2.9M	-3.3M	-1.6M	-1.5M
Income (Loss) On Equity Invest.	-700K	-	-	-	-
Currency Exchange Gains (Loss)	-4.3M	-1.4M	4.7M	-4.3M	9.9M
Other Non Operating Income (Expenses)	1.5M	-2.2M	200K	-3.5M	400K
EBT, Excl. Unusual Items	790M	606M	571M	628M	704M
Restructuring Charges	-	-	-	-	-12.8M
Merger & Related Restructuring Charges	-	-9.6M	-300K	-300K	-2.3M
Impairment of Goodwill	-16.9M	-29M	-94.9M	-	-
Gain (Loss) On Sale Of Investments	600K	-	-3.4M	-	-
Gain (Loss) On Sale Of Assets	-	12.8M	-	-	-
Asset Writedown	-	-	-34.7M	-48.8M	-159M
Other Unusual Items	-	-	-	-	-4M
EBT, Incl. Unusual Items	774M	581M	437M	579M	526M
Income Tax Expense	176M	140M	114M	154M	129M
Earnings From Continuing Operations	598M	441M	323M	425M	397M
Net Income to Company	598M	441M	323M	425M	397M
Minority Interest	2.9M	11.8M	34.8M	7.1M	600K
Net Income - (IS)	601M	452M	358M	432M	398M
Net Income to Common Incl Extra Items	601M	452M	358M	432M	398M
Net Income to Common Excl. Extra Items	601M	452M	358M	432M	398M
Per Share Items
Net EPS - Basic	5.08	3.84	3.03	3.67	3.37
Basic EPS - Continuing Operations	5.08	3.84	3.03	3.67	3.37
Basic Weighted Average Shares Outstanding	118M	118M	118M	118M	118M
Net EPS - Diluted	5.06	3.82	3.01	3.64	3.34
Diluted EPS - Continuing Operations	5.06	3.82	3.01	3.64	3.34
Diluted Weighted Average Shares Outstanding	119M	118M	119M	119M	119M
Normalized Basic EPS	4.2	3.31	3.31	3.39	3.73
Normalized Diluted EPS	4.18	3.3	3.29	3.37	3.71
Dividend Per Share	0.85	0.85	0.85	0.9	0.98
Payout Ratio	12.16	22.37	28.02	-	26.69
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	1B	814M	858M	948M	1.13B
EBITA	860M	696M	691M	740M	912M
EBIT	801M	613M	569M	638M	695M
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	22.69	24.13	26.18	26.63	24.5
Total Current Taxes	181M	208M	195M	199M	122M
Total Deferred Taxes	-5.8M	-67.9M	-81M	-44.8M	6.8M
Normalized Net Income	497M	391M	391M	400M	440M
Interest on Long-Term Debt	2.5M	2.8M	4.3M	6.6M	6.5M
Non-Cash Pension Expense	300K	300K	300K	600K	700K
Supplemental Operating Expense Items
Selling and Marketing Expenses	576M	702M	726M	784M	791M
General and Administrative Expenses	243M	253M	295M	314M	320M
Research And Development Expense From Footnotes	447M	490M	540M	554M	682M
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., Other (Total)	12.4M	13M	19.7M	23.4M	26.5M
Total Stock-Based Compensation	12.4M	13M	19.7M	23.4M	26.5M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	804M	553M	352M	450M	570M
Total Cash And Short Term Investments	804M	553M	352M	450M	570M
Accounts Receivable, Total	591M	740M	729M	792M	766M
Other Receivables	111M	117M	132M	146M	176M
Total Receivables	701M	857M	860M	939M	943M
Inventory	635M	737M	908M	1.04B	960M
Prepaid Expenses	23.9M	31.4M	38.6M	33M	47.2M
Other Current Assets, Total	43.7M	38.8M	45.4M	42.3M	21M
Total Current Assets	2.21B	2.22B	2.21B	2.5B	2.54B
Gross Property Plant And Equipment	2.45B	2.7B	2.95B	3.32B	3.34B
Accumulated Depreciation	-1.22B	-1.33B	-1.44B	-1.63B	-1.69B
Net Property Plant And Equipment	1.22B	1.37B	1.51B	1.7B	1.66B
Long-term Investments	34.5M	71.2M	206M	180M	114M
Goodwill	670M	812M	699M	730M	728M
Other Intangibles, Total	412M	625M	529M	492M	402M
Accounts Receivable Long-Term	12.6M	12.9M	7.7M	9.1M	10.3M
Loans Receivable Long-Term	24.7M	17.1M	14.2M	15.6M	15.4M
Deferred Tax Assets Long-Term	29.1M	58.7M	92.7M	146M	108M
Other Long-Term Assets, Total	3M	2.6M	-	100K	-
Total Assets	4.62B	5.19B	5.26B	5.77B	5.57B
Liabilities
Accounts Payable, Total	240M	269M	265M	272M	262M
Accrued Expenses, Total	318M	373M	379M	452M	430M
Short-term Borrowings	26.3M	53.9M	29M	17.7M	20.7M
Current Portion of Long-Term Debt	48.6M	107M	107M	94.4M	78.6M
Current Portion of Leases	24.8M	26.2M	27.4M	29.4M	32.1M
Current Income Taxes Payable	67.4M	49M	52.8M	35.4M	18.3M
Unearned Revenue Current, Total	84M	88.5M	80.1M	87.4M	77.9M
Other Current Liabilities	147M	164M	147M	147M	145M
Total Current Liabilities	956M	1.13B	1.09B	1.13B	1.06B
Long-Term Debt	265M	225M	234M	207M	211M
Long-Term Leases	97.6M	93.7M	121M	143M	119M
Deferred Tax Liability Non Current	61.1M	53M	11.1M	25.7M	26M
Other Non Current Liabilities	62.6M	41.2M	53.2M	49.2M	48M
Total Liabilities	1.44B	1.54B	1.51B	1.56B	1.47B
Common Stock, Total	12M	12M	12M	12M	12M
Additional Paid In Capital	63.7M	3.06B	3.42B	3.67B	4.01B
Retained Earnings	1.21B	452M	358M	432M	398M
Treasury Stock	-10.3M	-36M	-19.1M	-42.9M	-40M
Comprehensive Income and Other	1.85B	114M	-18.5M	137M	-278M
Total Common Equity	3.12B	3.6B	3.75B	4.2B	4.1B
Minority Interest	51.4M	38.7M	-	6.1M	3.9M
Total Equity	3.17B	3.64B	3.75B	4.21B	4.11B
Total Liabilities And Equity	4.62B	5.19B	5.26B	5.77B	5.57B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	118M	118M	118M	118M	118M
ECS Total Common Shares Outstanding	118M	118M	118M	118M	118M
Book Value / Share	26.41	30.54	31.76	35.66	34.77
Tangible Book Value	2.04B	2.17B	2.52B	2.98B	2.97B
Tangible Book Value Per Share	17.27	18.36	21.37	25.29	25.2
Total Debt	462M	505M	519M	491M	461M
Net Debt	-341M	-47.2M	166M	40.9M	-108M
Debt Equivalent of Unfunded Proj. Benefit Obligation	34.6M	12.5M	20.2M	23.3M	19.5M
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	51.4M	38.7M	-	6.1M	3.9M
Equity Method Investments, Total	900K	900K	800K	800K	700K
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	264M	326M	385M	419M	393M
Inventories - Work In Process, Total	51.7M	89.8M	99.8M	110M	108M
Inventories - Finished Goods, Total	362M	364M	470M	546M	496M
Land - (BS)	54.5M	56.5M	58.5M	63.6M	63M
Buildings, Total	743M	824M	846M	954M	990M
Machinery, Total	626M	682M	785M	808M	872M
Full Time Employees	12.08K	12.56K	13.41K	14.15K	14.56K
Part Time Employees	295	578	573	607	664
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	43.1M	47.7M	51.7M	33.7M	35.8M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	601M	452M	358M	432M	398M
Depreciation & Amortization - CF	172M	147M	196M	242M	256M
Amortization of Goodwill and Intangible Assets - (CF)	59.4M	82.7M	122M	102M	217M
Depreciation & Amortization, Total	231M	230M	318M	344M	473M
Amortization of Deferred Charges, Total - (CF)	16.9M	18.1M	15.7M	16.3M	6.4M
(Gain) Loss on Sale of Investments - (CF)	-600K	-	-	-	-
Asset Writedown & Restructuring Costs	16.9M	29M	130M	22.9M	131M
(Income) Loss On Equity Investments - (CF)	700K	-	-	-	-
Stock-Based Compensation (CF)	12.4M	13M	19.7M	23.4M	26.5M
Other Operating Activities, Total	-30.8M	-111M	-192M	-121M	-175M
Change In Accounts Receivable	23.6M	-146M	-13.7M	-53.7M	-29M
Change In Inventories	-62.4M	-92.1M	-193M	-85.1M	-10.1M
Change In Accounts Payable	24.2M	9.9M	3.4M	-600K	3.4M
Change in Other Net Operating Assets	-21.8M	71.9M	-400K	88.4M	-35.6M
Cash from Operations	811M	475M	445M	667M	788M
Capital Expenditure	-290M	-287M	-338M	-346M	-335M
Sale of Property, Plant, and Equipment	20M	17.4M	6.4M	9.4M	10.4M
Cash Acquisitions	-36.8M	-205M	-	-8.8M	-130M
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-400K	-53.8M	-157M	-14.6M	-6.2M
Other Investing Activities, Total	-	-	-	-	-100K
Cash from Investing	-307M	-528M	-489M	-360M	-462M
Long-Term Debt Issued, Total	18.2M	67.7M	38.9M	9.8M	33.6M
Total Debt Issued	18.2M	67.7M	38.9M	9.8M	33.6M
Long-Term Debt Repaid, Total	-68.3M	-53.4M	-73.7M	-84.6M	-63.2M
Total Debt Repaid	-68.3M	-53.4M	-73.7M	-84.6M	-63.2M
Issuance of Common Stock	-	-	12.7M	-	-
Repurchase of Common Stock	-3.8M	-157M	-	-37.6M	-18.2M
Common Dividends Paid	-73.1M	-101M	-100M	-	-106M
Common & Preferred Stock Dividends Paid	-73.1M	-101M	-100M	-	-106M
Other Financing Activities, Total	-	-100K	-	-100M	-1.5M
Cash from Financing	-127M	-244M	-122M	-213M	-155M
Foreign Exchange Rate Adjustments	39.2M	38.7M	-29.7M	13.9M	-48.4M
Miscellaneous Cash Flow Adjustments	-	-	100K	-	100K
Net Change in Cash	416M	-258M	-195M	109M	123M
Supplemental Items
Cash Interest Paid	9.1M	4.1M	4.4M	16M	15.8M
Cash Income Tax Paid (Refund)	185M	224M	204M	206M	152M
Levered Free Cash Flow	395M	168M	159M	298M	616M
Unlevered Free Cash Flow	401M	170M	162M	308M	626M
Change In Net Working Capital	70.1M	187M	209M	129M	-20.6M
Net Debt Issued / Repaid	-50.1M	14.3M	-34.8M	-74.8M	-29.6M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	11.72	7.83	6.81	7.23	7.66
Return on Total Capital	15.17	9.86	8.45	8.89	9.37
Return On Equity %	21.15	12.95	8.73	10.68	9.54
Return on Common Equity	21.64	13.47	9.72	10.86	9.57
Margin Analysis
Gross Profit Margin %	58.16	55.97	55.99	55.66	56.73
SG&A Margin	24.24	26.6	27.77	27.58	27.3
EBITDA Margin %	29.74	22.68	23.34	23.82	27.76
EBITA Margin %	25.48	19.38	18.82	18.59	22.41
EBIT Margin %	23.72	17.08	15.48	16.03	17.07
Income From Continuing Operations Margin %	17.72	12.28	8.78	10.68	9.75
Net Income Margin %	17.8	12.6	9.73	10.86	9.77
Net Avail. For Common Margin %	17.8	12.6	9.73	10.86	9.77
Normalized Net Income Margin	14.71	10.89	10.65	10.05	10.82
Levered Free Cash Flow Margin	11.7	4.67	4.34	7.48	15.13
Unlevered Free Cash Flow Margin	11.87	4.75	4.41	7.73	15.37
Asset Turnover
Asset Turnover	0.79	0.73	0.7	0.72	0.72
Fixed Assets Turnover	2.94	2.77	2.56	2.49	2.43
Receivables Turnover (Average Receivables)	5.68	5.39	5	5.23	5.22
Inventory Turnover (Average Inventory)	2.4	2.33	1.97	1.81	1.76
Short Term Liquidity
Current Ratio	2.31	1.96	2.03	2.2	2.39
Quick Ratio	1.57	1.25	1.12	1.22	1.42
Operating Cash Flow to Current Liabilities	0.85	0.42	0.41	0.59	0.74
Days Sales Outstanding (Average Receivables)	64.24	67.66	72.94	69.93	69.89
Days Outstanding Inventory (Average Inventory)	152.01	156.73	185.69	201.79	206.96
Average Days Payable Outstanding	54.15	54.71	54.53	51.95	57.95
Cash Conversion Cycle (Average Days)	162.1	169.68	204.1	219.77	218.9
Long Term Solvency
Total Debt/Equity	14.57	13.87	13.83	11.65	11.24
Total Debt / Total Capital	12.72	12.18	12.15	10.44	10.1
LT Debt/Equity	11.43	8.74	9.47	8.29	8.04
Long-Term Debt / Total Capital	9.98	7.68	8.32	7.43	7.23
Total Liabilities / Total Assets	31.24	29.76	28.65	27.02	26.35
EBIT / Interest Expense	88.02	149.51	129.32	39.87	43.97
EBITDA / Interest Expense	113.4	205.59	201.66	61.38	73.92
(EBITDA - Capex) / Interest Expense	81.52	135.66	124.77	39.77	52.7
Total Debt / EBITDA	0.45	0.6	0.58	0.5	0.4
Net Debt / EBITDA	-0.33	-0.06	0.19	0.04	-0.09
Total Debt / (EBITDA - Capex)	0.62	0.91	0.94	0.77	0.55
Net Debt / (EBITDA - Capex)	-0.46	-0.08	0.3	0.06	-0.13
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.27	6.31	2.38	8.31	2.26
Gross Profit, 1 Yr. Growth %	11.97	0.39	2.42	7.68	4.22
EBITDA, 1 Yr. Growth %	26.05	-19.01	0.61	10.54	19.15
EBITA, 1 Yr. Growth %	30.19	-17.57	-0.62	6.99	23.34
EBIT, 1 Yr. Growth %	30.78	-24.65	-7.18	12.11	8.92
Earnings From Cont. Operations, 1 Yr. Growth %	48.55	-26.35	-26.74	31.69	-6.63
Net Income, 1 Yr. Growth %	48.64	-24.74	-20.96	20.86	-8.03
Normalized Net Income, 1 Yr. Growth %	35.34	-22.51	0.14	2.17	9.22
Diluted EPS Before Extra, 1 Yr. Growth %	48.39	-24.51	-21.2	20.93	-8.24
Accounts Receivable, 1 Yr. Growth %	-1.22	25.31	-1.55	8.74	-3.29
Inventory, 1 Yr. Growth %	17.11	18.9	23.24	14.18	-7.48
Net Property, Plant and Equip., 1 Yr. Growth %	14.62	11.85	9.94	12.59	-2.26
Total Assets, 1 Yr. Growth %	17.54	12.63	1.4	9.71	-3.38
Tangible Book Value, 1 Yr. Growth %	48.94	6.67	16.53	18.13	-0.33
Common Equity, 1 Yr. Growth %	28.46	15.81	4.11	12.06	-2.44
Cash From Operations, 1 Yr. Growth %	39.17	-42.39	-6.25	49.82	18.15
Capital Expenditures, 1 Yr. Growth %	4.54	-1.17	18	2.22	-3.04
Levered Free Cash Flow, 1 Yr. Growth %	39.73	-56.88	-22.77	95.59	106.85
Unlevered Free Cash Flow, 1 Yr. Growth %	34.34	-56.85	-22.4	89.85	103.34
Dividend Per Share, 1 Yr. Growth %	37.1	0	0	5.88	8.89
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.35	7.29	4.33	5.3	5.24
Gross Profit, 2 Yr. CAGR %	15.71	7.02	1.4	5.02	5.94
EBITDA, 2 Yr. CAGR %	35.04	1.09	-7.62	5.46	14.76
EBITA, 2 Yr. CAGR %	41.22	2.6	-9.49	3.11	14.86
EBIT, 2 Yr. CAGR %	43.61	0.04	-16.37	2.01	10.5
Earnings From Cont. Operations, 2 Yr. CAGR %	48.93	4.6	-26.54	-1.77	10.89
Net Income, 2 Yr. CAGR %	48.44	5.77	-22.87	-2.26	5.43
Normalized Net Income, 2 Yr. CAGR %	46.49	3.2	-11.91	1.15	6.07
Diluted EPS Before Extra, 2 Yr. CAGR %	48.32	5.84	-22.87	-2.38	5.34
Accounts Receivable, 2 Yr. CAGR %	3.43	11.26	11.07	3.47	2.55
Inventory, 2 Yr. CAGR %	13.26	16.64	21.05	18.62	2.78
Net Property, Plant and Equip., 2 Yr. CAGR %	9.3	13.22	10.89	11.25	4.9
Total Assets, 2 Yr. CAGR %	10.49	14.91	6.87	5.47	2.96
Tangible Book Value, 2 Yr. CAGR %	39.93	25.71	11.49	17.33	8.51
Common Equity, 2 Yr. CAGR %	19.04	21.76	9.8	8.01	4.56
Cash From Operations, 2 Yr. CAGR %	41.01	-9.71	-26.51	18.51	33.04
Capital Expenditures, 2 Yr. CAGR %	3.18	1.64	7.99	9.82	-0.44
Levered Free Cash Flow, 2 Yr. CAGR %	97.07	-22.96	-36	20.13	101.11
Unlevered Free Cash Flow, 2 Yr. CAGR %	87.26	-24.43	-35.91	21.38	96.44
Dividend Per Share, 2 Yr. CAGR %	111.51	17.09	0	2.9	7.38
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	11.72	10.3	5.63	5.64	4.28
Gross Profit, 3 Yr. CAGR %	14.67	11.05	5.47	3.45	4.75
EBITDA, 3 Yr. CAGR %	24.59	13.92	2.5	-1.92	9.83
EBITA, 3 Yr. CAGR %	28.54	17.27	1.52	-4.3	9.45
EBIT, 3 Yr. CAGR %	30.13	16.43	-2.43	-7.79	4.26
Earnings From Cont. Operations, 3 Yr. CAGR %	32.8	17.78	-7.11	-10.76	-3.42
Net Income, 3 Yr. CAGR %	32.83	18.37	-4.02	-10.41	-4.22
Normalized Net Income, 3 Yr. CAGR %	32.77	19.08	2.17	-7.45	4.05
Diluted EPS Before Extra, 3 Yr. CAGR %	32.61	18.43	-4.07	-10.4	-4.38
Accounts Receivable, 3 Yr. CAGR %	6.29	10.26	6.81	10.29	1.16
Inventory, 3 Yr. CAGR %	14.86	14.22	18.8	18.71	9.19
Net Property, Plant and Equip., 3 Yr. CAGR %	10.85	10.14	12.12	11.45	6.55
Total Assets, 3 Yr. CAGR %	9.62	11.1	10.22	7.81	2.43
Tangible Book Value, 3 Yr. CAGR %	36.72	27.6	22.57	13.66	11.12
Common Equity, 3 Yr. CAGR %	17.44	17.82	15.56	10.55	4.41
Cash From Operations, 3 Yr. CAGR %	26.59	5.21	-8.57	-6.82	18.39
Capital Expenditures, 3 Yr. CAGR %	8.62	1.71	6.83	6.03	5.36
Levered Free Cash Flow, 3 Yr. CAGR %	20.24	18.16	-17.39	-8.53	43.97
Unlevered Free Cash Flow, 3 Yr. CAGR %	18.71	14.24	-18.38	-7.96	44.14
Dividend Per Share, 3 Yr. CAGR %	34.42	64.77	11.09	1.92	4.86
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9.93	9.42	8.7	8.27	5.47
Gross Profit, 5 Yr. CAGR %	12.27	10.64	9.58	8.6	5.65
EBITDA, 5 Yr. CAGR %	18.01	11.37	10.56	11.48	7.24
EBITA, 5 Yr. CAGR %	20.29	13.75	11.28	11.39	6.66
EBIT, 5 Yr. CAGR %	21.88	12.87	9.38	10.43	2.55
Earnings From Cont. Operations, 5 Yr. CAGR %	27.26	13.16	4.8	9.53	-0.29
Net Income, 5 Yr. CAGR %	27.4	13.7	6.87	9.64	-0.34
Normalized Net Income, 5 Yr. CAGR %	23.64	14.85	13.02	11.56	3.71
Diluted EPS Before Extra, 5 Yr. CAGR %	27.3	13.7	6.76	9.62	-0.41
Accounts Receivable, 5 Yr. CAGR %	4.86	9.97	8.18	7.49	5.09
Inventory, 5 Yr. CAGR %	9.43	14.15	16.75	15.96	12.11
Net Property, Plant and Equip., 5 Yr. CAGR %	10.77	14	10.87	10.59	9.17
Total Assets, 5 Yr. CAGR %	8.8	11.65	8.46	8.82	7.25
Tangible Book Value, 5 Yr. CAGR %	25.5	20.18	25.87	23.38	16.74
Common Equity, 5 Yr. CAGR %	14.04	15.71	14.24	13.79	11.03
Cash From Operations, 5 Yr. CAGR %	19.3	6.84	2.18	10.35	6.23
Capital Expenditures, 5 Yr. CAGR %	4.48	9.33	8.36	4.88	3.86
Levered Free Cash Flow, 5 Yr. CAGR %	30.88	6.93	-6.84	23.97	16.85
Unlevered Free Cash Flow, 5 Yr. CAGR %	28.69	5.54	-7.51	21.92	15.97
Dividend Per Share, 5 Yr. CAGR %	20.59	20.11	19.42	36.49	9.59